Increased Funding Will Help Protect Patients and Consumers

ROCKVILLE, Md., May 8 /PRNewswire-USNewswire/ -- The U.S. Pharmacopeial (USP) Convention welcomes the substantial increase in funding for the Food and Drug Administration (FDA) contained in President Obama's proposed budget. Following the Obama administration's voiced support for additional funding for FDA, this proposed budget will increase the agency's ability to protect American patients and consumers. The proposed Obama budget requests $295 million in additional authority appropriations (excluding user fees), which increases the total budgeted to $2.350 billion in FY 2010. This represents a 19 percent increase over FY 2009.

"Given growing concerns about FDA's ability to protect American food and drug supplies," said Roger L. Williams, M.D., chief executive officer of USP, "it is especially gratifying to see the Obama administration providing significantly increased support for the agency and its new management. The added dollars will allow FDA to better monitor the flow of medications and foods that are imported to the United States from around the world, and to bolster efforts to secure the safety of domestic supplies. This will go a long way toward increasing public confidence in FDA."

USP is a scientific nonprofit organization that sets official standards for the quality, identity, and strength of medicines, and also sets widely observed standards for the quality of food ingredients and dietary supplements. FDA and USP have worked together for many years in a strong public-private partnership that has done much to help ensure the quality, safety and benefit of medicines and foods.

USP--Advancing Public Health Since 1820

The United States Pharmacopeial (USP) Convention is a scientific, nonprofit, standards-setting organization that advances public health through public standards and related programs that help
'/>"/>

• AIDS/HIV
• Bioinformatics
• Biotechnology
• Biochemistry
• Cancer
• Cell Biology
• Developmental Biology
• Ecology
• Environment
• Evolution
• Food Technology
• Gene
• Genetics
• Genomics
• Health/Medicine
• Immunology
• Microarray
• Microbiology
• Molecular
• Marine Biology
• Nanobiotechnology
• Neurobiology
• Plant Sciences
• Stem Cell
• Systems Biology
• Virus
• Women Health

• Abortion
• Aches
• ADHD
• Addiction
• Alcohol
• Allergy
• Alternative Medicine
• Alzheimer's Dementia
• Anxiety/Stress
• Arthritis
• Autism
• Bacteria
• Blood
• Bird Flu/Avian Flu
• Bones
• Breast Cancer
• Cancer
• Cardiovascular
• Cervical Cancer
• Chikungunya
• Cholesterol
• Clinical Trials
• Colorectal Cancer
• Conferences
• Crohn's
• Cystic Fibrosis
• Dengue
• Dentistry
• Depression
• Diabetes
• Drug
• Eating Disorders
• Education
• Epilepsy
• Erectile Dysfunction
• Eye Health/Blindness
• Fertility
• Flu/Cold
• GastroIntestinal
• Genetics
• Gout
• Headache/Migraine
• Hearing/Deafness
• HIV/AIDS
• Huntington's Disease
• Hypertension
• Immune System/Vaccines
• Insurance
• Infectious Diseases
• Irritable-Bowel Syndrome
• Internet
• Leukemia
• Lifestyle
• Liver Disease/Hepatitis
• Lung Cancer
• Lupus
• Mad Cow Disease
• Medical Devices
• Medical Students/Training
• Medicare/Medicaid
• Medico
• Men's health
• Mental Health
• MRI/Ultrasound
• MRSA/Drug Resistance
• Multiple Sclerosis
• Muscular Dystrophy
• Neurology
• Nursing
• Nutrition/Diet
• Obesity/Weight Loss
• Pain/Anesthetics
• Parkinson's Disease
• Pediatrics/Children's Health
• Pharma/Biotech Industry
• Pharmacy/Pharmacists
• Pregnancy
• Premature
• Prostate
• Psychology/Psychiatry
• Rehabilitation
• Respiratory/Asthma
• SARS
• Schizophrenia
• Seniors/Aging
• Sexual Health
• Sleep/Sleep Disorders
• Smoking
• Statins
• Stem Cell Research
• Stroke
• Surgery
• Transplants/Organ Donations
• Viruses
• Water - Air Quality
• Women's Health